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Objective To determine tetanus antitoxin levels in adults and the aged.
Methods This study was conducted on 249 adults over 40 years of age who applied to a
blood-withdrawal unit in Kayseri, Central Anatolia. Tetanus toxoid-specific antibodies
were measured in serum by enzyme-linked immunosorbent assay (ELISA).
Results In the research group, only 63 persons (25.3%) were found to have protective
levels (>0.1 IU/mL) of tetanus antitoxin. Antibody levels were significantly higher in
educated people (30.7%), in those under 50 years of age (38.2%), in those who had been
vaccinated at least twice (47.6%), and in those vaccinated not more than 10 years
previously (58.3%). There was no association between antibody level and sex, occupation
or place of residence.
Conclusion Our findings indicated that tetanus antibody values were under the pro-
tective level for most adults over 40 years of age, and vaccination programs directed at the
adult population should be developed.
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I N T R O D U C T I O N
Tetanus is not very common but is associated with
a rather high mortality. In 1994 and 1995, 280 cases
occurred in Turkey (the annual morbidity rates
were 0.25 and 0.20/100 000, respectively), and 84
individuals died (29.8%) [1]. The fatality rate of the
disease is greater in neonatals and the elderly. For
example, in the USA the fatality rates are 75% in
the neonatal period, around 5% in adults under
50 years of age, and 42% in adults above 50 years of
age [2]. Neonatal deaths to tetanus bring this
disease into the top ten, with regard to deaths
from infectious diseases, in the world [3]. How-
ever, not only because of improvements in immu-
nization during pregnancy, but also because of
births taking place in safer conditions, a reduction
in the number of neonatal tetanus cases has been
observed recently. In spite of this, particularly in
developed countries, the elderly are at greater risk
of tetanus than are other groups. For instance, in
the USA tetanus in those over 60 years of age
occurs at a six-fold higher rate than in other age
groups (0.13 versus 0.02 in 100 000) [4]. Further-
more, in a study conducted in Italy, the annual
incidence among subjects over 65 years of age was
found to be approximately ten times greater than
that among younger individuals [5]. Forty-three of
48 annual tetanus deaths occurring in Italy (89.6%),
29 of 32 in Argentina (90.6%), and all of 12 in
France and 16 in Portugal, took place in adults
and the elderly over 40 years of age [6].
Deaths due to tetanus in Turkey are also occur-
ring more frequently in the older age group. While
the rate of those over 40 years of age who died of
tetanus as a percentage of total tetanus deaths was
27.4% in 1989, more recently this rate ranged from
44.8% to 60.6% [7–9].
It is obvious that vaccination is the most impor-
tant measure for effective and extensive protection
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against tetanus. In Turkey, vaccination against
tetanus began in the mid-1960s [10], although
somewhat irregularly. A systematic vaccination
program, including tetanus vaccination, was start-
ed by means of a campaign implemented in 1985.
At present, after a primary series of three doses of
tetanus toxoid, a booster dose is administered to
infants at the age of 16 months. Other boosters are
administered in classes 1 and 5 of primary school
and in class 1 of high school. Although, while
women receive two doses of tetanus toxoid during
pregnancy (29.3% of pregnant women received
two doses in 1998), and men are vaccinated during
their military service, there is no comprehensive
tetanus vaccination program for adults.
In this study, we aimed to determine the tetanus
antitoxin levels of the adult and aged populations
and to suggest strategies accordingly.
M A T E R I A L S A N D M E T H O D S
This study was conducted between 1 and 30 June
2000 with adults over 40 years of age who applied
to the blood-withdrawal unit of the Medical
Faculty of Erciyes University, Kayseri, Central
Anatolia, for various reasons. On the assumption
that 20% of the adults and elderly in this age group
will have protective levels of antitoxin, the
required sample size was calculated as 246 at a
confidence interval of 95% and with a deviation of
5%. According to this, 249 of those who applied
were included in the study, and the distribution of
sex and age was taken into account. Sera separated
from venous blood samples were stored at 20 8C
until the time of study. IgG class tetanus antitoxin
antibodies in the sera were measured by ELISA
(Virotech, Ru¨sselheim, Germany). The patient sera
were diluted (1/100), and patient sera, standard
and control sera were pipetted onto microtiter
strips. Incubation was at 37 8C for 30 min. The
microtiter strips were washed four times. The con-
jugate was pipetted, and this was followed by in-
cubation. The microtiter strips were washed again,
and the substrate was pipetted and incubated in
the dark. After pipetting, stop solution extinctions
were measured at 450/620 nm with a photometer.
The assessment was done according to the
method used by Schroder et al. [11]; antitoxin
values below 0.1 IU/mL were considered to be
below the protective level, and values of 0.1 IU/
mL and above were considered to be at a protec-
tive level.
The data were analyzed using SPSS 9.0 for
Windows. The chi-square test was used for statis-
tical analyses.
R E S U L T S
One hundred and fourteen (45.8%) of those in-
cluded in the study were male, and 135 (54.2%)
were female. The mean age was 56.2 10.6 years
(range 40–85) (male 58.2 11.3, range 40–85;
female 54.5 9.6, range 40–80). It was observed
that approximately one-third (29.3%) were illiter-
ate or had not finished any school, 37% were
primary school graduates, 8.4% were secondary
school graduates, and about one-quarter (25.3%)
were high school or university graduates. Approx-
imately two-thirds of the adults included in this
study (62.2%) resided in cities, 21.7% in towns, and
16.1% in villages or the country.
According to the statements of the subjects, the
rate of those with up-to-date vaccinations against
tetanus was 29.3%. The vaccination status of the
whole group is given in Table 1.
While the tetanus vaccination status is similar in
both sexes, the vaccination rate, which is 42.1% in
the 40–49-years age group, decreased to 24.0% in
the 50–59-years age group, and to 19.4% in the
over-60 s (w2¼ 13.500; DF¼ 2; P< 0.05).
Of those who stated that they had been vaccinat-
ed against tetanus, 15.1% had been vaccinated
within the last 5 years, 17.8% had been vaccinated
6–10 years ago, and 67.1% more than 10 years
before.
A protective level of antitoxin (>0.1 IU/mL) was
detected in 65 of the 249 individuals (25.3%)
included in this study. The antitoxin levels of
adults according to various factors are shown in
Table 2.
Table 1 Tetanus vaccination status in adults
Vaccination status Number %
Not vaccinated 118 47.4
Did not remember whether
or not vaccinated
58 23.3
Vaccinated 73 29.3
Vaccinated once 48 19.3
Vaccinated twice or more 21 8.4
Did not remember number
of vaccinations
4 1.6
Total 249 100.0
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Table 2 shows that no significant association was
found between place of residence, sex, occupation
and tetanus antitoxin levels. While the rate among
women whose antitoxin levels are at a protective
level is 21.5%, and this rate rises to 29.8% in males;
this difference between the sexes is not statistically
significant. Although the rates of protective level
of antitoxin are 19.0% among housewives and
32.6% among civil servants and the retired, no
statistically significant association was found with
occupation.
On the other hand, the rate of protective level
of antitoxin, which was 38.2% in the 40–49-years
age group, decreased to approximately 20% after
50 years of age, which is a statistically significant
difference. In addition, while the rate of those
whose antitoxin values were at sufficient levels
was 12.3% in those who had not finished any
school, this rate was over 30% in those who had
attended primary school and above; which con-
stitutes a statistically significant difference.
The number of individuals who stated that they
had been vaccinated one or more times was 73
(29.3%). Although 62 persons who did not remem-
ber whether they had been vaccinated or how
many times they had been vaccinated were
excluded, antitoxin levels were at protective levels
in 16.1% of those who stated that they had never
Table 2 Antitoxin levels of the study group according to various factors
Having protective level of antitoxin
Total number Number % v2 P
Age groups 9.575 <0.05
40–49 76 29 38.2
50–59 75 15 20.0
60þ 98 19 19.4
Total 249 63 25.3
Residential place 0.394 >0.05
Village/town 40 11 27.5
District center 54 12 22.2
City center 155 40 25.8
Total 249 63 25.3
Sex 2.276 >0.05
Male 114 34 29.8
Female 135 29 21.5
Total 249 63 25.3
Educational status 9.210 <0.05
Illiterate/did not finish school 73 9 12.3
Primary or secondary school 113 35 31.0
High school and above 63 19 30.2
Total 249 63 25.3
Occupation 5.304 >0.05
Housewife 121 23 19.0
Official—retired 95 31 32.6
Other 33 9 27.3
Total 249 63 25.3
Number of vaccinations 11.390 <0.05
Not vaccinated 118 19 16.1
Vaccinated once 48 14 29.2
Vaccinated twice or more 21 10 47.6
Totala 187 43 23.0
Last vaccination 6.277 <0.05
Within the last 5 years 11 7 63.6
6–10 years ago 13 7 53.8
More than 10 years ago 49 14 28.6
Totalb 73 28 38.4
aOne hundred and sixty-two individuals who did not remember how many times they were vaccinated were excluded
from the assessment.
bOne hundred and seventy-six individuals who had no vaccination or who did not remember whether they were
vaccinated were excluded from the assessment.
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been vaccinated. This rate increased to 29.2% in
those who stated that they had been vaccinated
only once before, and to 47.6% in those who stated
that they had been vaccinated twice or more. The
difference between the groups was also found to
be statistically significant.
While the rate of individuals who had protective
levels of antitoxin was 28.6% in those who stated
that they had been vaccinated more than 10 years
ago, this rate reached 53.8% in those vaccinated
6–10 years before, and 63.6% in those vaccinated
within the last 5 years. The difference between the
groups is also statistically significant.
The relationship between antitoxin level and
time since vaccination among persons with a simi-
lar history of vaccination is shown in Table 3.
As demonstrated by Table 3, no relationship
was found between antitoxin levels and time since
last vaccination in those who had been vaccinated
once. However, the rate of protective antitoxin
reached 100% in those who had been vaccinated
twice or more, and within the last 5 years. This rate
was determined as 50% in those who had been
vaccinated 6–10 years before, and 27.3% in those
who had been vaccinated more than 10 years
before.
D I S C U S S I O N
Tetanus is a disease that can be prevented by the
antibodies that develop as a result of vaccination.
In this study, it was found that 25.3% of adults over
40 years of age had protective levels of antitoxins.
This rate changed depending on the developmen-
tal level of the country and the success of immu-
nization programs. For example, in one of the two
studies conducted in the USA, the rate of those
who had a protective level of antibodies was 27.8%
in adults over 70 years of age; in the other study, it
was 50% in those individuals above 65 years of age
in an urban comprehensive care geriatric center
[12,13]. A study conducted in Australia was one of
those studies in which a protective level of anti-
toxin was found to be highest in adults; it was
detected in 52% of the population over 49 years of
age [14]. In a study conducted in males between 21
and 54 years of age in Israel, where booster vacci-
nations are given to soldiers, the rate of those with
a protective level of antitoxins reached 77.3% [15].
The antitoxin positivity rate was found to be only
27.7% in a group including young adults over
22 years of age in Tokyo [16]. The rate of those
with protective levels of antitoxins ranged from
18.2% to 41.3% in studies conducted in different
age groups in Turkey [17–19].
In our study, the rate of those with protective
levelsofantitoxinwasapproximatelytwo-foldhigh-
er in the group under 50 years of age than in the
aged. Vaccinations administered to those under 50
years of age during school, military service or
pregnancy may explain this. Since the immuniza-
tion program against tetanus began approximately
35 years ago in our country, neither the 50–59-
years age group nor the over-60 years age group
received tetanus toxoid at school. Furthermore, as
the rate of non-vaccinated persons increases with
age in the adults in our study, and the time since
last vaccination increases with age in countries like
Turkey, where immunization against tetanus can-
not be carried out systematically, the association
with age is to be expected. Levels of antitoxin
decreased inversely proportional to age in other
countries which have not yet fully established their
immunization programs for adults [14,20].
Table 3 Protective antitoxin levels according to number of vaccinations and last vaccination time
Having protective
level of antitoxin
Number of
vaccinations
remembered Last vaccination time
Total
number Number % v2 P
One Within the last 5 years 5 1 20.0 0.479 >0.05
6–10 years before 7 3 42.9
More than 10 years before 36 10 27.8
Total 48 14 29.2
Two or more Within the last 5 years 4 4 100.0 6.239 <0.05
6–10 years before 6 3 50.0
More than 10 years before 11 3 27.3
Total 21 10 47.6
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On the other hand, the rate of those with a
protective level of antitoxin among primary school
graduates and above was seen to be higher than
that among those who did not graduate from
primary school and who were illiterate. Indivi-
duals who attend schools are routinely vaccinated
against tetanus during their education (in classes 1
and 5 in primary schools and in class 1 in high
schools in Turkey). They attend health institutions
more often and consequently get more boosters
during pregnancy and in cases of trauma than
those who are in the illiterate group. In addition,
considering that the rate of those who did not
finish any school reaches 40.8% among people
60 years old and above, it can be suggested that
the illiterate population is older and, accordingly,
their antitoxin levels are lower. Antitoxin levels
were higher in those with more education in a
study conducted in the USA [12].
Although antitoxin levels in males were shown
to be slightly higher than those in females in our
study, the difference is not statistically significant.
The antitoxin levels in males were higher in stu-
dies conducted in several countries [12–14]. This
situation may be due to immunization during their
military service, and to men being more subject to
trauma outside and during work, and consequently
being vaccinated more often. However, it is observ-
ed that tetanus vaccinations given to women, par-
ticularly during pregnancy, balance this situation.
It is known that housewives and farmers are the
groups in which the disease occurs most fre-
quently, and the groups which must be protected
by providing higher levels of antibodies [4,21].
Although the difference is not statistically signifi-
cant, the rate of protective levels of antitoxin was
lower in housewives than in the other occupa-
tional groups in our study.
The rate of protective levels of antitoxins was
found to be three-fold higher in those who stated
that they had received tetanus vaccinations twice
or more than in those who had never been vacci-
nated. It is known that booster injections followed
by primary vaccination are necessary to elevate
antitoxin levels to protective levels and maintain
these levels. As the number of vaccinations
increases, the rate of protective levels will also
increase. It is suggested by the WHO that a pro-
tective level of antibodies is achieved in 80–90% of
women following two doses in pregnancy, and in
95–98% following the third dose; protection lasts
for 5 years and may be extended up to 10–20 years
with the fourth and fifth doses [22]. However, the
number of these vaccinations will be more signifi-
cant if added to primary vaccination; so while
there was a significant difference in terms of hav-
ing protective levels of antibodies between the
group whose primary vaccination was complete
and the group which had never been vaccinated in
a study conducted in Turkey, the antibody levels
of those vaccinated once or twice and those of the
non-vaccinated group were found to be similar
[19].
While antitoxin values are at protective levels in
28.6% of individuals whose last vaccination was
more than 10 years ago, this rate reaches 63.6% in
those vaccinated within the last 5 years. In a study
involving age groups ranging from 1 day old to 85
years old in Turkey, a protective level of antitoxin
was detected in only 13.3% of those whose last
vaccination was 10 years before, and was consid-
erably higher in those vaccinated 2–5 years before
[19]. The continuity of protection from the time of
the last vaccination may vary, depending on the
vaccination having been administered as a pri-
mary vaccination or series of vaccinations. Our
study supported this. There was no relationship
between antitoxin levels and time from last vacci-
nation in those who stated that they had been
vaccinated once. However, it was determined that
the antitoxin level was higher in those who stated
that they had been vaccinated twice or more and in
those vaccinated within the last 5 years. The time
from last vaccination may vary, depending on
whether the vaccination was administered as a
primary vaccination or number of vaccinations.
According to the immunization program for preg-
nant women suggested by the WHO, a sufficient
level of immunity is ensured for 20 years following
the routine fifth vaccination. In our study, the
reason for the lack of sufficient levels of antitoxin
in around 35–45% of those vaccinated within the
last 10 years may possibly be due to the incomplete
vaccination of these individuals previously. In
fact, while it is reported in some studies that a
strong antibody response, which varies among
individuals, may result from a booster dose given
as late as 30 years after primary vaccination, many
studies indicate that a booster dose given 15 years
following the primary vaccination will have a very
low probability of stimulating a response [22]. In
another study, it was found that 32% of the elderly
who did not have sufficient levels of antitoxins had
been vaccinated within the last 10 years (21%
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within the last 3–6 years); and this was attributed
to the reduction of antibodies in the elderly due to
the shortened immunologic memory [23].
The results obtained in the study are as follows:
 47.4% of those included in this study stated that
they had never been vaccinated against tetanus.
 Of the adults over 40 years of age, 25.3% had
tetanus antitoxin protective levels.
 Tetanusantitoxinlevelsweremuchlower in those
over 50 years of age who stated they had been
vaccinated only once before or not at all, and who
had been vaccinated more than 10 years before.
 100.0% of those vaccinated twice or more within
the last 5 years had a protective antitoxin level.
In light of these results, we believe that immu-
nization programs for tetanus should be extended
to adults and the aged in addition to children and
pregnant women. Routine vaccination, which is dis-
continued after military service in men and preg-
nancy in women, should be maintained in the
context of a program which should be supported
by antibody studies, e.g. once every 10 years.
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